Treatment

Key populations and their sexual partners account for 65% of new HIV infections but are largely left out of both HIV and COVID-19 responses

The UNAIDS 2021 report shows that 19 countries achieved the 90–90–90 targets by 2020.

Only 54% of children living with HIV are on treatment

Injectable HIV treatment is approved for use in some countries.

Evidence suggests that people living with HIV have a higher risk of becoming seriously ill from COVID-19.

The WHO HIV drug resistance report shines a light on the emerging threat of HIV drug resistance and recommends the use of dolutegravir in countries where resistance is already prevalent.

The oldest documented person living with HIV, known as ‘The Lisbon Patient’, dies at age 100.

Primary results from the largest community-randomised trial of the universal HIV test-and-treat strategy find that treatment alone is unlikely to end the epidemic.

HIV organisations across the globe endorse Undetectable = Untransmittable a statement declaring that individuals with suppressed viral loads cannot pass on HIV

The Center for Disease Control (CDC) approves the use of Post-exposure Prophylaxis in the general public for the first time.